| RS534570905 |
PUS3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS534581445 |
CARD14
|
Health Risk |
Conflicting classifications of pathogenicity |
Autoinflammatory syndrome, Autoinflammatory syndrome |
| RS534585904 |
SLC25A13
|
Health Risk |
Pathogenic/Likely pathogenic |
Citrin deficiency, Citrullinemia |
| RS534592472 |
PPT1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronal ceroid lipofuscinosis 1, Neuronal ceroid lipofuscinosis 1 |
| RS534596867 |
PKDCC
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, PKDCC-related disorder |
| RS534598133 |
GALC
|
Health Risk |
Conflicting classifications of pathogenicity |
Galactosylceramide beta-galactosidase deficiency, Inborn genetic diseases |
| RS5346 |
EDNRB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hirschsprung disease, susceptibility to |
| RS534607483 |
ACTN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Dilated cardiomyopathy 1AA |
| RS534613934 |
TTN
|
Health Risk |
Likely pathogenic |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS534616210 |
HADHB
|
Health Risk |
Pathogenic/Likely pathogenic |
Mitochondrial trifunctional protein deficiency, Mitochondrial trifunctional protein deficiency 1 |
| RS534622837 |
ATP7B
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilson disease, Wilson disease |
| RS534627748 |
TMEM231
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome 20, Meckel syndrome |
| RS534630703 |
PKD1
|
Health Risk |
Pathogenic |
Autosomal dominant polycystic kidney disease, Autosomal dominant polycystic kidney disease |
| RS534632699 |
CACNA1H
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperaldosteronism, familial |
| RS534635326 |
PC
|
Health Risk |
Likely pathogenic |
Pyruvate carboxylase deficiency, Pyruvate carboxylase deficiency |
| RS534636474 |
MEIS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiac malformation, cleft lip/palate |
| RS534638031 |
PIEZO1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS534639518 |
AP3D1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS534646732 |
SORL1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS534646949 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Inborn genetic diseases |
| RS534647044 |
ACADVL
|
Health Risk |
Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS534659292 |
SLC37A4
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease, type I |
| RS534665632 |
RNF213
|
Health Risk |
Conflicting classifications of pathogenicity |
Moyamoya disease 2, Moyamoya disease 2 |
| RS534665666 |
LAMA3
|
Health Risk |
Likely pathogenic |
Junctional epidermolysis bullosa gravis of Herlitz, Laryngo-onycho-cutaneous syndrome |
| RS534671822 |
SRD5A2
|
Health Risk |
Pathogenic |
3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency, 3-Oxo-5 alpha-steroid delta 4-dehydrogenase deficiency |
| RS534680895 |
ANK1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spherocytosis type 1, Spherocytosis |
| RS534685803 |
GMPPB
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A14 |
| RS534691598 |
FOXP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS534696343 |
ATP1A2
|
Health Risk |
Pathogenic/Likely pathogenic |
Fetal akinesia, respiratory insufficiency |
| RS534696523 |
PKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Polycystic kidney disease, Kidney failure |
| RS534700620 |
COL11A2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS534705500 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS534708439 |
COG1
|
Health Risk |
Conflicting classifications of pathogenicity |
COG1 congenital disorder of glycosylation, Inborn genetic diseases |
| RS534717081 |
RBP3
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Retinal dystrophy |
| RS534723946 |
SETX
|
Health Risk |
Conflicting classifications of pathogenicity |
Amyotrophic lateral sclerosis type 4, Charcot-Marie-Tooth disease |
| RS534738790 |
NOD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Blau syndrome, Regional enteritis |
| RS534741485 |
ADGRE2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS534750502 |
PMPCA
|
Health Risk |
Likely pathogenic |
Autosomal recessive spinocerebellar ataxia 2, Autosomal recessive spinocerebellar ataxia 2 |
| RS534752839 |
MYO18B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS534756824 |
LOXHD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 77, Autosomal recessive nonsyndromic hearing loss 77 |
| RS534758736 |
OTOF
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 9, Autosomal recessive nonsyndromic hearing loss 9 |
| RS534764707 |
OTX2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS534766933 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS534770840 |
SEC23B
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital dyserythropoietic anemia, type II |
| RS534772399 |
MAPRE2
|
Health Risk |
Conflicting classifications of pathogenicity |
Skin creases, congenital symmetric circumferential |
| RS534777436 |
COL11A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Stickler syndrome type 2, Fibrochondrogenesis 1 |
| RS534778154 |
COL12A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ullrich congenital muscular dystrophy 2, Bethlem myopathy 2 |
| RS534783808 |
DNAH8
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS534788595 |
ACOT1;HEATR4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS534801018 |
MACF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS534802983 |
MYH11
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Aortic aneurysm |
| RS534811966 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS534816625 |
TOR1AIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2Y, Inborn genetic diseases |
| RS534821207 |
MESP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Spondylocostal dysostosis 2, autosomal recessive |
| RS534831346 |
PKHD1
|
Health Risk |
Likely pathogenic |
Caroli disease, Caroli disease |
| RS534835336 |
CPS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital hyperammonemia, type I |
| RS534838107 |
LIPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Lysosomal acid lipase deficiency, Wolman disease |
| RS534846786 |
NEU1
|
Health Risk |
Pathogenic |
Sialidosis, Sialidosis |
| RS534858065 |
HLCS
|
Health Risk |
Conflicting classifications of pathogenicity |
Holocarboxylase synthetase deficiency, Inborn genetic diseases |
| RS534858651 |
GNPTAB
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucolipidosis type II, Pseudo-Hurler polydystrophy |
| RS534860826 |
CA5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency, Hyperammonemic encephalopathy due to carbonic anhydrase VA deficiency |
| RS534864280 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS534874513 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS534879577 |
SMPD4
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with microcephaly, arthrogryposis |
| RS534880813 |
AP3D1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, AP3D1-related disorder |
| RS534886444 |
SETX
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease, Amyotrophic lateral sclerosis type 4 |
| RS534890707 |
NBAS
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS534912670 |
BCHE
|
Health Risk |
Pathogenic |
Deficiency of butyrylcholinesterase, Deficiency of butyrylcholinesterase |
| RS534913868 |
FBN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Marfan syndrome, Familial thoracic aortic aneurysm and aortic dissection |
| RS534923467 |
CTC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Dyskeratosis congenita, Inborn genetic diseases |
| RS534934297 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS534940271 |
TMPO
|
Health Risk |
Conflicting classifications of pathogenicity |
Loeys-Dietz syndrome 2, Loeys-Dietz syndrome 2 |
| RS534944818 |
LAMA5
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS534949106 |
HSPG2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS534950651 |
TCIRG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive osteopetrosis 1, Autosomal recessive osteopetrosis 1 |
| RS534950713 |
CFHR5
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, CFHR5 deficiency |
| RS534951317 |
OTOG
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive nonsyndromic hearing loss 18B, Autosomal recessive nonsyndromic hearing loss 18B |
| RS534960245 |
ATP7B
|
Health Risk |
Conflicting classifications of pathogenicity |
Wilson disease, ATP7B-related disorder |
| RS534966725 |
RAD50
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS534966818 |
HADH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinemic hypoglycemia, familial |
| RS534974144 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Renal cell carcinoma |
| RS534978828 |
PLOD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, kyphoscoliotic type 1 |
| RS534983760 |
AXIN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Oligodontia-cancer predisposition syndrome, Hereditary cancer-predisposing syndrome |
| RS5350 |
EDNRB
|
Health Risk |
Conflicting classifications of pathogenicity |
Hirschsprung disease, susceptibility to |
| RS535000990 |
MBD5
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, autosomal dominant 1 |
| RS535002208 |
SETBP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS535007570 |
COL6A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Bethlem myopathy 1A, Collagen 6-related myopathy |
| RS535008556 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS535012160 |
EVC
|
Health Risk |
Conflicting classifications of pathogenicity |
Ellis-van Creveld syndrome, Curry-Hall syndrome |
| RS535014010 |
DSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 11, Cardiomyopathy |
| RS535018963 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypobetalipoproteinemia 1, Hypercholesterolemia |
| RS535021192 |
DSE
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, musculocontractural type 2 |
| RS535022442 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
LAMA2-related muscular dystrophy, Inborn genetic diseases |
| RS535025599 |
LIG4
|
Health Risk |
Conflicting classifications of pathogenicity |
DNA ligase IV deficiency, Severe combined immunodeficiency due to DCLRE1C deficiency |
| RS535030441 |
SPG7
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary spastic paraplegia 7, Hereditary spastic paraplegia |
| RS535037838 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Isolated focal cortical dysplasia type II |
| RS535038304 |
ADGRV1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS535041755 |
APOB
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hypobetalipoproteinemia 1, Hypercholesterolemia |
| RS535056127 |
PITX2
|
Health Risk |
Conflicting classifications of pathogenicity |
PITX2-Related Eye Abnormalities, Axenfeld-Rieger syndrome type 1 |
| RS535062329 |
BAG3
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Myofibrillar myopathy 6 |